Growel Remedies Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 17-12-2024
- Paid Up Capital ₹ 2.46 M
as on 17-12-2024
- Company Age 30 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 5.00 Cr
as on 17-12-2024
- Satisfied Charges ₹ 7.00 Cr
as on 17-12-2024
- Revenue -2.52%
(FY 2022)
- Profit -4.54%
(FY 2022)
- Ebitda -152.59%
(FY 2022)
- Net Worth 52.76%
(FY 2022)
- Total Assets 23.49%
(FY 2022)
About Growel Remedies
The Corporate was formerly known as Growel Capital Services Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.46 M.
The company currently has active open charges totaling ₹5.00 Cr. The company has closed loans amounting to ₹7.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Rahul Bishnoi, Ashwani Sharma, and Tejasvi Bishnoi serve as directors at the Company.
- CIN/LLPIN
U51397DL1994PLC060862
- Company No.
060862
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
12 Aug 1994
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Growel Remedies?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Tejasvi Bishnoi  | Director | 12-Aug-1994 | Current |
| Rahul Bishnoi | Director | 15-Oct-1994 | Current |
| Ashwani Sharma | Director | 14-Nov-2011 | Current |
Financial Performance and Corporate Structure Insights of Growel Remedies.
Growel Remedies Limited, for the financial year ended 2022, experienced Minor drop in revenue, with a 2.52% decrease. The company also saw a slight decrease in profitability, with a 4.54% decrease in profit. The company's net worth Soared by an impressive increase of 52.76%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Growel Remedies?
In 2022, Growel Remedies had a promoter holding of 75.50% and a public holding of 24.50%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Medicamen Biotech LimitedActive 30 years 11 monthsRahul Bishnoi and Ashwani Sharma are mutual person
- Medicamen Life Sciences Private LimitedActive 2 years 4 months
Rahul Bishnoi and Ashwani Sharma are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 21 Feb 2019 | ₹5.00 Cr | Open |
Others Creation Date: 24 Jul 2018 | ₹7.00 Cr | Satisfied |
How Many Employees Work at Growel Remedies?
Unlock and access historical data on people associated with Growel Remedies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Growel Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Growel Remedies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
